Cargando…

P19-43. Regulatory T cell epitopes in a dendritic cell-targeted HIV vaccine delivery platform

Detalles Bibliográficos
Autores principales:	Weber, C, Mosie, L, Veelken, H, Martin, W
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767874/ http://dx.doi.org/10.1186/1742-4690-6-S3-P363

Ejemplares similares

Variable processing and presentation of HIV epitopes in dendritic cells and macrophages to CD8 T cells
por: Gourdain, P, et al.
Publicado: (2012)

P18-05. Evidence of escape mutations in HLA-A02 epitopes in HIV-1-positive patients after dendritic cell-based therapeutic vaccination with CD8 epitopes
por: Vinner, L
Publicado: (2009)

Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine
por: De Groot, AS, et al.
Publicado: (2012)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

P16-43. A hierarchy of antiviral activity between different epitope-specific CD8+ T cells can be attributed to early elimination of HIV-infected cells
por: Payne, RP, et al.
Publicado: (2009)

Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
por: Levy, Y, et al.
Publicado: (2012)

HIV triggers immunoregulatory dendritic cells and regulatory T cells through the non-canonical NF-kB pathway
por: Manches, O, et al.
Publicado: (2012)

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success
por: De Groot, AS, et al.
Publicado: (2009)

Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
por: Capasso, Cristian, et al.
Publicado: (2015)

P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009)

Enhanced induction of HIV-specific CTL by dendritic cell-targeted delivery of SOCS-1 siRNA
por: Subramanya, Sandesh, et al.
Publicado: (2010)

Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design
por: Wieczorek, L, et al.
Publicado: (2012)

P18-10. Ability of HIV antigens-pulsed monocyte-derived dendritic cells to induce HIV-specific T cell response: potential use in therapeutic vaccine
por: Silveira, GG, et al.
Publicado: (2009)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

S43. Dendritic cell vaccination combined with CTLA4 blockade
por: Thielemans, K, et al.
Publicado: (2014)

Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines
por: Dillman, Robert O, et al.
Publicado: (2015)

Novel strategies for HIV-1 epitope delivery using foamy viral hybrid proteins and vectors
por: Mühle, M, et al.
Publicado: (2012)

P19-10. Induction of dendritic cell maturation by a liposomally-delivered multivalent HIV vaccine
por: Azizi, A, et al.
Publicado: (2009)

P55. Dendritic cell vaccination for postremission therapy in AML
por: Lichtenegger, FS, et al.
Publicado: (2014)

A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design
por: Chen, Y, et al.
Publicado: (2012)

Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
por: De Groot, AS, et al.
Publicado: (2012)

P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
por: Cobb, AJ, et al.
Publicado: (2009)

T cell stimulation by dendritic cell-tumor cell hybrids is enhanced in the presence of free dendritic cells
por: Pinho, Mariana P, et al.
Publicado: (2013)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals
por: Yassine Diab, B, et al.
Publicado: (2009)

Regulatory B cells are induced in untreated HIV-1 infection and suppress HIV-1 specific T cell responses
por: Liu, J, et al.
Publicado: (2012)

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
por: Hulot, SL, et al.
Publicado: (2012)

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
por: Lederle, A, et al.
Publicado: (2009)

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes
por: Su, B, et al.
Publicado: (2012)

Engineered microneedle arrays for transcutaneous HIV vaccine delivery
por: DeMuth, P, et al.
Publicado: (2012)

P18-03. Dendritic cell-based immune therapy against HIV-1
por: Gruters, RA, et al.
Publicado: (2009)

Loading dendritic cells from HIV-1 infected patients with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses
por: Climent, N, et al.
Publicado: (2012)

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1
por: Guilà, M, et al.
Publicado: (2009)

Epitope-based vaccines: SARS – a model
por: Freund, Natalia Tarnovitski, et al.
Publicado: (2006)

P18-02. Peptide pulsed dendritic cells allows for induction of polyfunctional CD4+ T cell responses and help CD8+ T cell targeting subdominant CTL epitopes
por: Fomsgaard, A, et al.
Publicado: (2009)

P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins
por: Ilyichev, A, et al.
Publicado: (2009)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

P10-04. Mechanisms of HIV-1 detection by plasmacytoid dendritic cells
por: Lepelley, A, et al.
Publicado: (2009)

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine
por: Martinon, F, et al.
Publicado: (2009)

P02-12. Bupivacaine, a local anaesthetic, enhances immunogenicity of a multiepitopic DNA vaccine containing HIV promiscuous CD4 T cell epitopes
por: Rosa, DS, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_204qo5lu0j7p32r6ptf21rqlqk